Fresenius Medical Care AG & Co. KGaA (FMS)

DE — Healthcare Sector
Peers: UHS  ADUS  HCA  THC  SEM  EHC  PNTG  INNV  ACHC  ENSG  SGRY  RMYHY  JNHMF  MFCSF  MCIOF  AIH 

Automate Your Wheel Strategy on FMS

With Tiblio's Option Bot, you can configure your own wheel strategy including FMS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol FMS
  • Rev/Share 66.4351
  • Book/Share 52.8423
  • PB 1.0199
  • Debt/Equity 0.7529
  • CurrentRatio 1.461
  • ROIC 0.0365

 

  • MktCap 14657647640.2465
  • FreeCF/Share 6.7587
  • PFCF 7.3913
  • PE 23.7117
  • Debt/Assets 0.3306
  • DivYield 0.0244
  • ROE 0.0438

 

  • Rating B+
  • Score 3
  • Recommendation Neutral
  • P/E Score 2
  • DCF Score 4
  • P/B Score 4
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Fresenius Medical Care Annual General Meeting: Strong Performance Against Its Strategic Plan Results in Highest Dividend per Share in Its History
FMS
Published: May 22, 2025 by: PRNewsWire
Sentiment: Neutral

Shareholders approved the proposed dividend of 1.44 Euro per share, representing a 21 percent increase year-over-year and marking the highest dividend in the company's history Excellent progress in the company's transformation and turnaround plans continues to strengthen the foundation for sustainable, profitable growth In 2024, organic revenue growth1 was 4 percent, and operating income increased by 18 percent on an outlook base2, coming in at the upper end of the company's outlook The company is well positioned for double digit earnings growth in 2025, translating to an 11-12 percent margin BAD HOMBURG, Germany , May 22, 2025 /PRNewswire/ -- Fresenius …

Read More
image for news Fresenius Medical Care Annual General Meeting: Strong Performance Against Its Strategic Plan Results in Highest Dividend per Share in Its History
Here's Why Fresenius (FMS) is a Strong Value Stock
FMS
Published: May 22, 2025 by: Zacks Investment Research
Sentiment: Positive

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Read More
image for news Here's Why Fresenius (FMS) is a Strong Value Stock
Fresenius (FMS) is a Great Momentum Stock: Should You Buy?
FMS
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Positive

Does Fresenius (FMS) have what it takes to be a top stock pick for momentum investors? Let's find out.

Read More
image for news Fresenius (FMS) is a Great Momentum Stock: Should You Buy?
Fresenius (FMS) is a Top-Ranked Momentum Stock: Should You Buy?
FMS
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Positive

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Read More
image for news Fresenius (FMS) is a Top-Ranked Momentum Stock: Should You Buy?
5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil
CLPT, DXCM, FMS, IDXX, NPCE
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Positive

Five high-flying medical instrument stocks are: DXCM, IDXX, NPCE, CLPT, FMS.

Read More
image for news 5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil
New Strong Buy Stocks for May 9th
BCRX, BNTGY, CBNA, FMS, WYY
Published: May 09, 2025 by: Zacks Investment Research
Sentiment: Positive

CBNA, FMS, BNTGY, WYY and BCRX have been added to the Zacks Rank #1 (Strong Buy) List on May 9, 2025.

Read More
image for news New Strong Buy Stocks for May 9th
Best Value Stocks to Buy for May 9th
BNTGY, FMS, SSUMY
Published: May 09, 2025 by: Zacks Investment Research
Sentiment: Positive

BNTGY, SSUMY and FMS made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 9, 2025.

Read More
image for news Best Value Stocks to Buy for May 9th
Best Income Stocks to Buy for May 9th
FMS, SSUMY
Published: May 09, 2025 by: Zacks Investment Research
Sentiment: Positive

SSUMY and FMS made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 9, 2025.

Read More
image for news Best Income Stocks to Buy for May 9th
FMS Stock Up as Q1 Earnings Beat Estimates, Revenues Up Y/Y
FMS
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive

Fresenius Medical's first-quarter results showcase a strong segmental performance, along with reiterating its 2025 outlook for revenue growth.

Read More
image for news FMS Stock Up as Q1 Earnings Beat Estimates, Revenues Up Y/Y
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
FMS
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Positive

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Read More
image for news Why Fresenius (FMS) is a Top Value Stock for the Long-Term
Fresenius Medical Care starts 2025 with strong organic revenue and income growth
FMS
Published: May 06, 2025 by: PRNewsWire
Sentiment: Neutral

Strong organic revenue growth1 of 5% driven by Care Enablement and Care Delivery Stable U.S. same market treatment development despite impact from a severe flu season FME25 savings of EUR 68 million contributed to earnings Operating income2 grew 11% at constant currency resulting in margin expansion Reported operating income grew by 35% and reported net income3 by 113% Net leverage ratio further improved to 2.8x and FY 2025 outlook confirmed BAD HOMBURG, Germany , May 6, 2025 /PRNewswire/ -- "The results of the first quarter of 2025 once again demonstrate our continuous operational and financial progress as we are executing …

Read More
image for news Fresenius Medical Care starts 2025 with strong organic revenue and income growth
Fresenius Medical Care tops market expectations in 1st quarter
FMS
Published: May 06, 2025 by: Reuters
Sentiment: Positive

World's largest dialysis specialist Fresenius Medical Care reported first-quarter results above analysts' expectations on Tuesday, as revenue grew organically in all its segments, it said.

Read More
image for news Fresenius Medical Care tops market expectations in 1st quarter
Watch These 3 MedTech Stocks for Q1 Earnings: Beat or Miss?
CLOV, FMS, MASI
Published: May 05, 2025 by: Zacks Investment Research
Sentiment: Positive

MedTech companies' quarterly results are likely to reflect strength in customer demand. Let's see how FMS, MASI and CLOV are placed ahead of their earnings releases.

Read More
image for news Watch These 3 MedTech Stocks for Q1 Earnings: Beat or Miss?
Should You Buy, Sell, or Hold FMS Stock Before Q1 Earnings?
FMS
Published: May 02, 2025 by: Zacks Investment Research
Sentiment: Positive

Fresenius Medical Care heads into the first quarter of 2025 with momentum from cost savings, innovation like the 5008X launch, and a steady recovery in U.S. treatment volumes.

Read More
image for news Should You Buy, Sell, or Hold FMS Stock Before Q1 Earnings?
Should Value Investors Buy Fresenius Medical Care AG & Co. (FMS) Stock?
FMS
Published: April 23, 2025 by: Zacks Investment Research
Sentiment: Positive

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Read More
image for news Should Value Investors Buy Fresenius Medical Care AG & Co. (FMS) Stock?
Here's Why Fresenius (FMS) is a Strong Value Stock
FMS
Published: April 17, 2025 by: Zacks Investment Research
Sentiment: Positive

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Read More
image for news Here's Why Fresenius (FMS) is a Strong Value Stock
Why Fresenius Medical Care Stock Might be a Great Pick
FMS
Published: April 17, 2025 by: Zacks Investment Research
Sentiment: Positive

FMS has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Read More
image for news Why Fresenius Medical Care Stock Might be a Great Pick
4 Top-Ranked High Earnings Yield Value Stocks to Buy Right Away
BABA, FMS, HLX, HRTG
Published: April 15, 2025 by: Zacks Investment Research
Sentiment: Positive

Unlock your portfolio value with value stocks like Alibaba, Fresenius Medical, Helix Energy and Heritage Insurance. All these stocks boast high earnings yield.

Read More
image for news 4 Top-Ranked High Earnings Yield Value Stocks to Buy Right Away
Here's Why Fresenius (FMS) is a Strong Momentum Stock
FMS
Published: April 11, 2025 by: Zacks Investment Research
Sentiment: Positive

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Read More
image for news Here's Why Fresenius (FMS) is a Strong Momentum Stock
Top 3 MedTech Stocks to Weather the Trump Tariff Turbulence
COR, FMS, PAHC
Published: April 09, 2025 by: Zacks Investment Research
Sentiment: Negative

In the present market turbulence, investors may want to consider discounted stocks, such as FMS, PAHC and COR.

Read More
image for news Top 3 MedTech Stocks to Weather the Trump Tariff Turbulence
Reasons to Add Fresenius Medical Stock to Your Portfolio Now
FMS
Published: April 04, 2025 by: Zacks Investment Research
Sentiment: Negative

FMS continues to gain traction on the back acquisitions & partnerships. A tough regulatory environment raises concerns.

Read More
image for news Reasons to Add Fresenius Medical Stock to Your Portfolio Now
4 Stocks Trading Near 52-Week High With More Upside Potential
FMS, TAP, TGI, THG
Published: April 04, 2025 by: Zacks Investment Research
Sentiment: Positive

Stocks like TAP, FMS, TGI and THG are seeing price strength and have a high chance of carrying the momentum forward.

Read More
image for news 4 Stocks Trading Near 52-Week High With More Upside Potential
4 Low-Beta Healthcare Stocks to Beat Trump's Tariff Blues
COR, FMS, GILD, LMAT
Published: April 04, 2025 by: Zacks Investment Research
Sentiment: Neutral

Healthcare stocks like GLID, COR, FMS and LMAT are a safe bet during times of market volatility.

Read More
image for news 4 Low-Beta Healthcare Stocks to Beat Trump's Tariff Blues
5 Relative Price Strength Stocks to Navigate Today's Market
ANIP, FMS, IHS, MD, TREE
Published: April 01, 2025 by: Zacks Investment Research
Sentiment: Positive

IHS, ANIP, MD, FMS and TREE are five stocks with explosive relative price strength.

Read More
image for news 5 Relative Price Strength Stocks to Navigate Today's Market
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
FMS
Published: April 01, 2025 by: Zacks Investment Research
Sentiment: Positive

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Read More
image for news Why Fresenius (FMS) is a Top Value Stock for the Long-Term
4 Best Value Stocks With Low PEG to Boost Your Portfolio Returns
FMS, JD, QFIN, UHS
Published: March 28, 2025 by: Zacks Investment Research
Sentiment: Positive

Here are four PEG-driven value stocks that fit our screening criteria: JD, UHS, FMS, and QFIN.

Read More
image for news 4 Best Value Stocks With Low PEG to Boost Your Portfolio Returns
3 Undervalued MedTech Stocks to Buy for 2025 Gains Amid S&P 500 Rally
FMS, INMD, PAHC
Published: March 26, 2025 by: Zacks Investment Research
Sentiment: Positive

Three discounted MedTech stocks to gain from the market rebound are PAHC, FMS and INMD.

Read More
image for news 3 Undervalued MedTech Stocks to Buy for 2025 Gains Amid S&P 500 Rally
5 Low Price-to-Book Stocks to Include in Your Portfolio for Gains
CIO, ENS, FMS, ITRI, JD
Published: March 26, 2025 by: Zacks Investment Research
Sentiment: Positive

The P/B ratio helps to identify low-priced stocks with high growth prospects. JD, CIO, FMS, ITRI and ENS are some such stocks.

Read More
image for news 5 Low Price-to-Book Stocks to Include in Your Portfolio for Gains
4 Value Picks That Could Weather Tariff Volatility and Slowing Growth
ENS, FMS, GM, ITRI
Published: March 24, 2025 by: Zacks Investment Research
Sentiment: Negative

Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. FMS, ENS, GM & ITRI boast a low P/CF ratio.

Read More
image for news 4 Value Picks That Could Weather Tariff Volatility and Slowing Growth
4 Top PEG Stocks Based on GARP Approach to Smart Investing
DAN, FMS, ITRI, JAZZ
Published: March 20, 2025 by: Zacks Investment Research
Sentiment: Neutral

Here are four discounted PEG stocks, JAZZ, FMS, DAN and ITRI, which qualify our screening criteria.

Read More
image for news 4 Top PEG Stocks Based on GARP Approach to Smart Investing

About Fresenius Medical Care AG & Co. KGaA (FMS)

  • IPO Date 1996-09-17
  • Website https://www.freseniusmedicalcare.com
  • Industry Medical - Care Facilities
  • CEO Ms. Helen Giza
  • Employees 112035

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.